bendamustine
PolandDrugs containing this active substance
-
The medicinal product is used for the treatment of chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma.
Form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine 26.1 mg ATC: L01AA09
Manufacturer: medac GmbH for Clinical Special Preparations